Sign up for a new account.
And get access to
The latest T1D content
Research that matters
Our daily questions
Sign up by entering your info below.
Reset Your Password
We will email you instructions to reset your
Introduction: The T1DX-QI is a Type 1 diabetes learning health system with thirteen endocrinology centers working collaboratively on the goal of improving outcomes for people with type 1 diabetes. The program is coordinated by the T1D Exchange in Boston, Massachusetts.
Objectives: For this project, “high-risk” is defined as having the two most recent HbA1c above 9% and at least two clinic visits in the preceding 12 months. There is an increased risk of acute and chronic complications among high-risk patients. Social, racial, and economic factors significantly contribute to further complicate the difficulty in reducing HbA1c levels among these patients.
This abstract describes how ten centers in the T1DX-QI used QI principles to test and expand different interventions in their clinic to reduce the proportion of high-risk patients. Some of the successful efforts include the increased engagement with a navigator, workflow redesign, developed mobile technology classes for insulin pump and CGM use, screening for depression, and addressing social determinants of health.
Methods: The centers shared data monthly with the coordinating office that used statistical process control charts to evaluate the effectiveness of the interventions (Figure 1).
Results: There was a collaborative-wide significant change of 3% from baseline. Six of ten centers met the collaborative goal of 35% that directly impacts over 200 patients in the piloted 12–26 year age group.
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Join our mailing list for more about T1D
- An Interview with Dr. Enrique Caballero: Providing Culturally-Oriented Care to the Latinx Communityby Taylor DennisOctober 14, 2021
- Dr. Osagie Ebekozien Awarded ISPAD’s Prize for Innovation in Pediatric Diabetes Careby Sarah TackettOctober 13, 2021
- T1D Exchange Research Highlights from ISPAD 2021by Sarah TackettOctober 13, 2021
- Status Update: Connected Insulin Delivery Devicesby Hope WarshawOctober 7, 2021
- Top Questions of the Day – September 2021by Sarah TackettSeptember 30, 2021